Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®

NCT02191293 · clinicaltrials.gov ↗

COMPLETED

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Viramune® tablets

Sponsor

Boehringer Ingelheim